Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Durvalumab prolongs overall survival whereas radiation dose escalation >66 Gy improves long-term local control in unresectable NSCLC stage III: Updated analysis of the Austrian radio-oncological lung cancer study association registry (ALLSTAR)

#2025
#JOURNAL OF THORACIC ONCOLOGY

PMU Authors
Franz Zehentmayr, Elvis Ruznic, Brane Grambozov

All Authors
Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marissa Klebermass, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Martin Heilmann, B. Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, M. Kazil, Heidi Stranzl, Karin Dieckmann

Journal association
JOURNAL OF THORACIC ONCOLOGY

Abstract